Lastly, to examine the effect of RIPK1 inhibition in a setting of coronary plaque rupture, which is related to clinical revascularization treatment of acute myocardial infarction, post-ischemia administration of RIPK1i reduced cardiac infarct size (Supplementary Figure S6). This evidence concerns the gene RIPK1 and myocardial infarction.